Trial Profile
Prevention of Post-Photocoagulation Macular Edema by Intravitreal Bevacizumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2009
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 10 Mar 2009 New trial record